Nobuyuki Katakami
-
- Lung Cancer Treatments and Mutations 17
- Lung Cancer Diagnosis and Treatment 5
- Cerebrovascular and Carotid Artery Diseases 3
- Oncology top 10%
- Lung Cancer Research Studies 6
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
-
- Cancer Genomics and Diagnostics 5
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Katsuhiro MasagoShiro FujitaYasushi YatabeReiko KajiAkito HataJumpei TakeshitaRyoji KatoYukihiro Imai
- Partner nations
- JapanUnited StatesNorway
In The Last Decade
Nobuyuki Katakami
24 papers receiving 612 citations
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 485
- Oncology 315
- Cancer Research 133
- Pathology and Forensic Medicine 52
- Radiation 17
Countries citing papers authored by Nobuyuki Katakami
This map shows the geographic impact of Nobuyuki Katakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyuki Katakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyuki Katakami more than expected).
Fields of papers citing papers by Nobuyuki Katakami
This network shows the impact of papers produced by Nobuyuki Katakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyuki Katakami. The network helps show where Nobuyuki Katakami may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobuyuki Katakami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 18 | |
| 2 | 2018 | 8 | |
| 3 | 2018 | 9 | |
| 4 | 2018 | 5 | |
| 5 | 2018 | 6 | |
| 6 | 2017 | 5 | |
| 7 | 2017 | 33 | |
| 8 | 2016 | 106 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 5 | |
| 11 | 2015 | 6 | |
| 12 | 2015 | 27 | |
| 13 | 2015 | 39 | |
| 14 | 2015 | 122 | |
| 15 | A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapy. | 2015 | 5 |
| 16 | 2014 | 22 | |
| 17 | 2014 | 2 | |
| 18 | 2010 | 0 | |
| 19 | 2010 | 28 | |
| 20 | 2008 | 40 |
About Nobuyuki Katakami
Nobuyuki Katakami is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 26 papers that have together received 621 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers), HER2/EGFR in Cancer Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (485 citations), Oncology (315 citations) and Cancer Research (133 citations). Nobuyuki Katakami has collaborated with scholars based in Japan, United States and Norway. Frequent co-authors include Katsuhiro Masago, Shiro Fujita, Yasushi Yatabe, Reiko Kaji, Akito Hata, Jumpei Takeshita, Ryoji Kato, Yukihiro Imai, Akito Hata and Chiyuki Okuda. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.